Sudeep Pharma IPO GMP: Day 1 IPO Live Updates

Click & Sign Up to Get Latest Updates on Sudeep Pharma IPO

The Sudeep Pharma IPO GMP is ₹14 as of 21st November 2025. It is a book-building IPO of ₹895.00 crore, comprising a fresh issue of 0.16 crore shares and an offer-for-sale of 1.35 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 28th November 2025. The face value of Sudeep Pharma IPO shares is ₹1 per share, and the IPO price band is set at ₹563 to ₹593 per share. Retail investors can bid for a minimum of 1 lot of 25 shares, worth ₹14,825.

Sudeep Pharma IPO Grey Market Premium

As of 21st November 2025, the GMP for the Sudeep Pharma IPO stands at ₹111 per share. Thus, the estimated listing price would be ₹704. This indicates that the estimated listing gain in this IPO could be 18.72%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for GMP updates on the Sudeep Pharma IPO.

Sudeep Pharma IPO Details

Explanation

Sudeep Pharma IPO: Sudeep Pharma IPO Limited has announced the issue price of ₹114 to ₹120 per share. With this IPO, the company allows retail investors to bid for one lot of 125 shares worth ₹15,000. The face value of Sudeep Pharma IPO Limited shares is ₹10 per share. The shares of Sudeep Pharma IPO Limited will be listed on BSE and NSE on its tentative listing day, 26th November 2025. Scroll down to view GMP updates and reviews of the Sudeep Pharma IPO. 

Objectives of the Sudeep Pharma IPO

The primary objective of the Sudeep Pharma IPO is to raise ₹895.00 crore. However, before applying for the IPO, it is essential to understand its secondary objectives. 

• Capital expenditure towards the procurement of machinery for the production line located at the Nandesari Facility.
• General corporate purposes

Sudeep Pharma IPO Registrar

According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Sudeep Pharma IPO GMP, allotment, or refund, please contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in  or +91-22-4918 6270.

Sudeep Pharma IPO Review  

The Sudeep Pharma IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Sudeep Pharma Limited’s revenue increased by 10% from ₹465.38 crore in March 2024 to ₹511.33 crore in March 2025. Moreover, the company’s PAT increased by 4% from ₹133.15 crores to ₹138.69 crores. Investors can analyse other relevant factors and make a decision accordingly. Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Sudeep Pharma IPO or not.

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Sudeep Pharma IPO.

The P/E ratio of Sudeep Pharma Limited’s shares is 47.61, and its Earnings Per Share (EPS) is 12.46. Thus, the Sudeep Pharma Limited IPO can deliver gains on its tentative listing day, 28th November 2025

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Mittal Solutions Limited are subject to change following the IPO. Refer to the table below for post-issue updates on these two metrics. 

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

FAQs on Sudeep Pharma IPO

What is the GMP of the Sudeep Pharma IPO?

As of 21st November 2025, the Sudeep Pharma IPO (Grey Market Premium) stands at ₹111. This suggests that the estimated listing price could be 18.72% of the share price.

What is the issue price of the Sudeep Pharma IPO?

The Sudeep Pharma IPO price range is ₹563.00 to ₹593.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 25 shares, worth ₹14,825. Moreover, HNIs are required to bid for a minimum of 14 lots  (350 shares) worth ₹2,07,550.

Who is the registrar of the Sudeep Pharma IPO?

According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Sudeep Pharma India IPO GMP, allotment, or refund, please contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in  or +91-22-4918 6270.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Sudeep Pharma IPO, download the Sudeep Pharma IPO RHP and Sudeep Pharma IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Recent Articles

Top 10 Penny Stocks in India  | Penny Stocks to Buy in 2025

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Accelerator IPO GMP & Review: Apply or Avoid?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates